Romoxipride
PubChem Notes:
Remoxipride An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.
Molecular Formula:
C16H23BrN2O3
InChI: InChI=1/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1/f/h18H
InChIKey: InChIKey=GUJRSXAPGDDABA-FPCLSXBCDK
SMILES: CCN1CCCC1CNC(=O)C2=C(C=CC(=C2OC)Br)OC
Names:
A 33547
BRN 4323708
FLA 731
Remoxiprida [INN-Spanish]
Remoxipride [USAN:BAN:INN]
Remoxipride
Remoxipridum [INN-Latin]
Romoxipride
(S)-3-Bromo-2,6-dimethoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
(-)-(S)-3-Brom-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamid
3-bromo-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2,6-dimethoxy-benzamide
Registries:
PubChem CID 54477
PubChem ID 192058
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|